Dr. Jasmine Cui, the Co-founder, Chairwoman, and CEO of InnoCare, said, “We are delighted to see the rapid progress of our five clinical trials for the TYK2 inhibitor. We hope this innovative drug ...

Experts emphasize that chronic hives require sustained treatment and management, shifting focus from trigger identification to long-term care.

With chronic urticaria on the rise, the CURE study calls for greater awareness on guideline-recommended classification, diagnostic workup, and treatment.

Medically reviewed by Marisa Garshick, MD Scientists now think chronic spontaneous urticaria (CSU) is an autoimmune disease, ...

New data challenge common beliefs about antihistamines, corticosteroids, and vaccines in chronic urticaria, with practical ...

In a healthy body, mast cells (the “lookout” cells of the immune system) only release histamine when they detect a foreign invader, like pollen or venom. In CSU, these cells dump histamine into the ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

71.9% of patients fail to follow prescribed treatment regimens due to barriers across patient, therapy, healthcare system, and socioeconomic domains. Only 33% use medications preventatively, with most ...

A panel of experts discuss the clinical trials of dupilumab, the resultant data, and the response of the FDA when approval was requested. Dupilumab has been evaluated in phase 3 clinical trials in ...

Patients with CSU have an elevated risk of anxiety and depression, necessitating comprehensive management strategies. Research is focused on identifying biomarkers and clinical characteristics to ...

Cold urticaria is a rare but potentially serious condition in which contact with cold weather causes the immune system to ...

The postpartum period is a time for recovery and healing. When you are busy juggling healing, establishing breastfeeding, and ...